Direxion Daily SandP Biotech Bull 3X ETF (LABU) |
| 195.92 -5.18 (-2.58%) 04-16 10:13 |
| Open: | 200.46 |
| High: | 201.8467 |
| Low: | 194.72 |
| Volume: | 94,038 |
| Market Cap: | 1,046(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 239.90 |
| Resistance 1: | 205.39 |
| Pivot price: | 172.56 |
| Support 1: | 161.23 |
| Support 2: | 133.93 |
| 52w High: | 205.39 |
| 52w Low: | 44.506 |
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 23 Jan 2026
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
Fri, 16 Jan 2026
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - AOL.com
Fri, 16 Jan 2026
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Wed, 19 Nov 2025
Top Performing Leveraged/Inverse ETFs: 11/16/2025 - ETF Database
Tue, 19 Aug 2025
LABU | Direxion Daily S&P Biotech Institutional Ownership - Quiver Quantitative
Tue, 19 Aug 2025
Top Performing Leveraged/Inverse ETFs: 08/17/2025 - ETF Database
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
